Triacetyl-resveratrol
| Code | Size | Price |
|---|
| CDX-A0350-M010 | 10 mg | £62.00 |
Quantity:
| CDX-A0350-M050 | 50 mg | £165.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
Ambient
Documents
Further Information
Alternate Names/Synonyms:
Acetyl-trans-resveratrol; 5-[(1E)-2-[4-(acetyloxy)phenyl]ethenyl]-1,3-Benzenediol-1,3-diacetate; 3,5,4'-Tri-O-acetylresveratrol; trans-3,5,4-Triacetylstilbene
Appearance:
White to off-white powder.
CAS:
42206-94-0
Class:
9
EClass:
32160000
Form (Short):
liquid
Handling Advice:
Protect from light and moisture.
Hazards:
H315, H317, H318, H335, H400
InChi:
InChI=1S/C20H18O6/c1-13(21)24-18-8-6-16(7-9-18)4-5-17-10-19(25-14(2)22)12-20(11-17)26-15(3)23/h4-12H,1-3H3/b5-4+
InChiKey:
PDAYUJSOJIMKIS-SNAWJCMRSA-N
Long Description:
Chemical. CAS: 42206-94-0. Formula: C20H18O6. MW: 354.35. Synthetic. A cell-permeable triacetate resveratrol prodrug that is easily converted to resveratrol by esterase activity and exhibits similar bioactivity as resveratrol in cell cultures. The compound induces p53 activity and inhibits proliferation in breast and prostate tumor cell lines.
MDL:
MFCD01546481
Molecular Formula:
C20H18O6
Molecular Weight:
354.35
Package Type:
Vial
PG:
III
Precautions:
P261, P273, P280, P305+P351+P338
Product Description:
A cell-permeable triacetate resveratrol prodrug that is easily converted to resveratrol by esterase activity and exhibits similar bioactivity as resveratrol in cell cultures. The compound induces p53 activity and inhibits proliferation in breast and prostate tumor cell lines.
Purity:
>98% (HPLC)
Signal word:
Danger
SMILES:
CC(OC1=CC=C(/C=C/C2=CC(OC(C)=O)=CC(OC(C)=O)=C2)C=C1)=O
Solubility Chemicals:
Soluble in DMSO (20mg/ml).
Source / Host:
Synthetic.
Transportation:
Excepted Quantity
UN Nummer:
UN3077
UNSPSC Category:
Natural Products/Extracts
UNSPSC Number:
12352200
Use & Stability:
Stable for at least 2 years after receipt when stored at RT.
References
(1) S. Kotagiri, et al.; J. Chem. Pharmac. Sci. 3, 191 (2010) | (2) P. Torres, et al.; J. Agric. Food Chem. 58, 807 (2010) | (3) K. Koide, et al.; ACS Med. Chem. Chem. Lett. 2, 270 (2011) | (4) T.C. Hsieh, et al.; Carcinogenesis 32, 93 (2011) | (5) T.C. Hsieh, et al.; Int. J. Cancer 129, 2732 (2011)
Related Products
| Product Name | Product Code | Supplier | Oxyresveratrol | CDX-O0035 | Chemodex | Summary Details | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Resveratrol | CDX-R0057 | Chemodex | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||